Killer-specific secretory (Ksp37) gene expression in subjects with Down’s syndrome

[1]  P. Van der valk,et al.  [Epstein-Barr virus infection with severe consequences. EBV, haemophagocytic lymphohistiocytosis and Hodgkin lymphoma with Down syndrome]. , 2014, Nederlands tijdschrift voor geneeskunde.

[2]  P. Bosco,et al.  Pericentrin expression in Down’s syndrome , 2013, Neurological Sciences.

[3]  Marilyn J Bull,et al.  Health Supervision for Children With Down Syndrome , 2001, Pediatrics.

[4]  P. Box.  Intrinsic abnormalities of lymphocyte counts in children with Down syndrome , 2006 .

[5]  W. Luttmann,et al.  Increase in Ksp37‐positive peripheral blood lymphocytes in mild extrinsic asthma , 2004, Clinical and experimental immunology.

[6]  R. Mrak,et al.  Trisomy 21 and the Brain , 2004, Journal of neuropathology and experimental neurology.

[7]  Masataka Nakamura,et al.  Accumulation of CD16+ Cells with Secretion of Ksp37 in Decidua at the End of Pregnancy , 2002, American journal of reproductive immunology.

[8]  K. Sugamura,et al.  A Novel Serum Protein That Is Selectively Produced by Cytotoxic Lymphocytes1 , 2001, The Journal of Immunology.

[9]  S. Romagnani,et al.  T-cell responses in allergy and asthma , 2001, Current opinion in allergy and clinical immunology.